StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
No sell-side coverage available for UG.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.87M | $10.55M | $7.58M | $5.32M |
Operating Income | $642.45K | $2.24M | $1.52M | $1.31M |
Net Income | $818.90K | $2.11M | $1.46M | $626.83K |
EPS (Diluted) | $0.18 | $0.46 | $0.32 | $0.26 |
Total Assets | $12.70M | $13.11M | $12.18M | $13.39M |
Total Liabilities | $1.80M | $1.88M | $1.60M | $1.93M |
Cash & Equivalents | $735.85K | $1.25M | $860.84K | $1.77M |
Free Cash Flow OCF − CapEx | $594.65K | $1.91M | $1.60M | $604.10K |
Shares Outstanding | 4.59M | 4.59M | 4.59M | 4.59M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-13 | $7.00 | $6.99 | -0.14% | 0.0M |
| 05-14 | $6.93 | $7.17 | +3.46% | 0.0M |
| 05-15 | $7.15 | $7.16 | +0.14% | 0.0M |
| 05-18 | $7.07 | $7.01 | -0.85% | 0.0M |
| 05-19 | $6.96 | $6.96 | +0.00% | 0.0M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.